This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shao, J. Articles by Sheng, H. Search for Related Content PubMed PubMed Citation Articles by Shao, J. Articles by Sheng, H.

Roles of Phosphatidylinositol 3'-Kinase and Mammalian Target of Rapamycin/p70 Ribosomal Protein S6 Kinase in K-Ras-Mediated Transformation of Intestinal Epithelial Cells

Department of Surgery and Sealy Center for Cancer Cell Biology, University of Texas Medical Branch, Galveston, Texas

Phosphatidylinositol 3'-kinase (PI3K) activity is required for Ras- mediated transformation of intestinal epithelial cells (IECs). The mammalian target of rapamycin (mTOR) and its downstream pathways control the translation of specific mRNAs that are required for cell proliferation and transformation. Here, we elucidated the roles of PI3K and mTOR in K-Ras-mediated transformation of IECs (IEC-6). Induction of K-Ras activated PI3K and mTOR in IECs. p70 ribosomal protein S6 kinase activity was induced by K-Ras in a PI3K- and mTOR-dependent manner. K-Ras did not significantly alter the phosphorylation of eukaryotic initiation factor 4E-binding protein 1. Treatment with either LY-294002 or rapamycin inhibited IEC proliferation and resulted in G₁ growth arrest. However, it was noted that inhibition of mTOR enhanced K-Ras-mediated morphological transformation and increased invasiveness of IECs in a mitogen-activated protein/extracellular signal-regulated kinase-dependent manner. Furthermore, inhibition of PI3K or mTOR impaired the growth of an array of colon cancer cells. Spindle transformation, reduced E-cadherin, and increased invasiveness were observed in LY-294002-treated Moser cells. Thus, our results suggest that K-Ras-mediated transformation of IECs involves activation of the PI3K/mTOR pathway. Inhibition of PI3K/mTOR activity leads to G₁ growth arrest of transformed IECs. On the other hand, inhibition of PI3K or mTOR may induce the epithelial to mesenchymal transdifferentiation of IECs under certain circumstances.

This article has been cited by other articles:

				S. Fernandez de Mattos, P. Villalonga, J. Clardy, and E. W-F. Lam FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells Mol. Cancer Ther., October 1, 2008; 7(10): 3237 - 3246. [Abstract] [Full Text] [PDF]

				T. Fujishita, K. Aoki, H. A. Lane, M. Aoki, and M. M. Taketo Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in Apc{Delta}716 mice PNAS, September 9, 2008; 105(36): 13544 - 13549. [Abstract] [Full Text] [PDF]

				E. Weisberg, L. Banerji, R. D. Wright, R. Barrett, A. Ray, D. Moreno, L. Catley, J. Jiang, E. Hall-Meyers, M. Sauveur-Michel, et al. Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cells Blood, April 1, 2008; 111(7): 3723 - 3734. [Abstract] [Full Text] [PDF]

				J. Shao, M.K. Washington, R. Saxena, and H. Sheng Heterozygous disruption of the PTEN promotes intestinal neoplasia in APCmin/+ mouse: roles of osteopontin Carcinogenesis, December 1, 2007; 28(12): 2476 - 2483. [Abstract] [Full Text] [PDF]

				L. Zhang, J. Li, L. H. Young, and M. J. Caplan AMP-activated protein kinase regulates the assembly of epithelial tight junctions PNAS, November 14, 2006; 103(46): 17272 - 17277. [Abstract] [Full Text] [PDF]

				E. W. Arvisais, A. Romanelli, X. Hou, and J. S. Davis AKT-independent Phosphorylation of TSC2 and Activation of mTOR and Ribosomal Protein S6 Kinase Signaling by Prostaglandin F2{alpha} J. Biol. Chem., September 15, 2006; 281(37): 26904 - 26913. [Abstract] [Full Text] [PDF]

				R. Guerriero, I. Parolini, U. Testa, P. Samoggia, E. Petrucci, M. Sargiacomo, C. Chelucci, M. Gabbianelli, and C. Peschle Inhibition of TPO-induced MEK or mTOR activity induces opposite effects on the ploidy of human differentiating megakaryocytes J. Cell Sci., February 15, 2006; 119(4): 744 - 752. [Abstract] [Full Text] [PDF]

				U. K. Basuroy and E. W. Gerner Emerging Concepts in Targeting the Polyamine Metabolic Pathway in Epithelial Cancer Chemoprevention and Chemotherapy J. Biochem., January 1, 2006; 139(1): 27 - 33. [Abstract] [Full Text] [PDF]

				R. E. Brown Morphoproteomic Analysis of Osteolytic Langerhans Cell Histiocytosis with Therapeutic Implications Ann. Clin. Lab. Sci., April 1, 2005; 35(2): 131 - 136. [Abstract] [Full Text] [PDF]

				B. Dasgupta, Y. Yi, D. Y. Chen, J. D. Weber, and D. H. Gutmann Proteomic Analysis Reveals Hyperactivation of the Mammalian Target of Rapamycin Pathway in Neurofibromatosis 1-Associated Human and Mouse Brain Tumors Cancer Res., April 1, 2005; 65(7): 2755 - 2760. [Abstract] [Full Text] [PDF]

				F. G. Buchanan, M. McReynolds, A. Couvillon, Y. Kam, V. R. Holla, R. N. DuBois, and J. H. Exton Requirement of phospholipase D1 activity in H-RasV12-induced transformation PNAS, February 1, 2005; 102(5): 1638 - 1642. [Abstract] [Full Text] [PDF]